| About the author: |
T. V. Bohdan, V. V. Bogdan, V. O. Sobol, I. V. Biliachenko, Yu. O. Moshkovska, Yu. V. Tyravska |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The purpose of the study was to improve the diagnosis of stable angina and unstable angina by determining the correlations between the development of myocardial ischemia and cardiac arrhythmias with disorders of cellular and humoral immunity in patients with coronary artery disease. Using the obtained results, further optimize the treatment of patients with stable and unstable angina pectoris. It was determined that in the stable angina pectoris the development of painful myocardial ischemia depends on the level of CD4+ subpopulation (T-helpers) and circulating immune complexes, the development of painless myocardial ischemia depends on the level of CD4+ and CD8+ subpopulations (T-suppressors). Coronary artery disease destabilization and group ventricular extrasystoles are associated with elevated CD4+ subpopulations, CD8+ subpopulations and circulating immune complexes levels. Pathogenetic links between coronary circulatory disorders and ectopic myocardial activity with the development of imbalance of cellular and humoral immunity in patients with stable and unstable angina pectoris confirm the theory of immune inflammation as one of the pathogenetic links in the development of coronary artery disease and encourage studies and development of new drugs in antianginal therapy algorithms. |
| Tags |
stable angina pectoris,unstable angina pectoris,painful ischemia,painless ischemia,extrasystole,immunity |
| Bibliography |
- Lyzohub VH, Zavalska TV, Stakhurska LA, Khalied Akhmad Khalil Abu Sara, Pliskevych DA, Dunaievskyi VI, Hrubnyk BP. Rol porushen humoralnoho imunitetu v rozvytku aterosklerozu i hostroho koronarnoho syndromu. Lik. Sprava. 2012;5: 63–72. [in Ukrainian]
- Arvanitis M, Lowenstein CJ. Dyslipidemia. Ann Intern Med. 2023 Jun;176(6): 81–96. https://doi.org/10.7326/aitc202306200
- Devkota S, Dhungana RR, Pandey AR, Poudel CM, Shrestha H, Bhattarai A. Risk Factors of Coronary Artery Disease: A Hospital-Based Study. J Nepal Health Res Counc. 2022 Nov 3;20(2):487–493. https://doi.org/10.33314/jnhrc.v20i02.4240
- Duggan JP, Peters AS, Trachiotis GD, Antevil JL. Epidemiology of Coronary Artery Disease. Surg Clin North Am. 2022 Jun;102(3):499–516. https://doi.org/10.1016/j.suc.2022.01.007.
- Durmaz E, Ikitimur B, Kilickiran Avci B, Atıcı A, Yurtseven E, Tokdil H, Ebren C, Polat F, Karaca O, Karadag B, Ongen Z. The clinical significance of premature atrial contractions: How frequent should they become predictive of new-onset atrial fibrillation. Ann Noninvasive Electrocardiol. 2020 May;25(3): e12718. https://doi.org/10.1111/anec.12718
- Fearon WF. The prognostic importance of silent ischemia. Int J Cardiol. 2019 Sep 15; 291:27–28. https://doi.org/10.1016/j.ijcard.2019.05.050
- Feng X, Zhang Y, Du M, Li S, Ding J, Wang J, Wang Y, Liu P. Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease. J Transl Med. 2022 Sep 5;20(1):399. https://doi.org/10.1186/s12967-022-03614-1
- Gallino A. The dilemma of detecting silent myocardial ischemia. Int J Cardiol. 2017 Oct 1; 244:86. https://doi.org/10.1016/j.ijcard.2017.06.049
- Laera N, Malerba P, Vacanti G, Nardin S, Pagnesi M, Nardin M. Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies. Life (Basel). 2023 Oct 27;13(11):2128. https://doi.org/10.3390/life13112128
- Larsen JB, Hvas AM. Fibrin clot properties in coronary artery disease: new determinants and prognostic markers. Pol Arch Intern Med. 2021 Nov 30;131(11):16113 https://doi.org/10.20452/pamw.16113
- Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021 Apr 8;22(8):3850. https://doi.org/10.3390/ijms22083850
- Shevchenko TI, Shaposhnyk OA, Sorokina SI, Kudrya IP, Efremenko VM. Features of management of patient with late diagnosted congenital heart disease. W Med Biology. 2019;1(67):111–116. https://doi.org/10.26724/2079-8334-2019-1-67-111
- Yazdani AN, Pletsch M, Chorbajian A, Zitser D, Rai V, Agrawal DK. Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(10):675–692. https://doi.org/10.1080/14779072.2023.2264779
|
| Publication of the article |
«World of Medicine and Biology» №4(86), 2023 year, 019-023 pages, index UDK 616.12–009.72 :612.017.1:616.12–005.4:616.12–008.318 |
| DOI |
10.26724/2079-8334-2023-4-86-19-23 |
